Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;29(50):2400074.
doi: 10.2807/1560-7917.ES.2024.29.50.2400074.

Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024

Dominique Ploin  1   2   3 , Mathilde Alexandre  3   4 , Bruno Ventelou  3   5 , Didier Che  6 , Bruno Coignard  6 , Nathalie Boulanger  3   7   8 , Christophe Burucoa  9   3   10 , François Caron  11   12   3 , Pierre Gallian  13   14   3 , Yves Hansmann  15   3 , Christian Lienhardt  16   3 , Philippe Minodier  17   3 , Henri Partouche  18   3 , Matthieu Revest  19   20   3 , Nadia Saidani  21   3 , Gilles Salvat  22   3 , Nicolas Vignier  23   24   3 , Sylvie Floreani  25 ; Collaborators’ group  26 ; Sabine Henry  3   27 , Bruno Pozzetto  28   29   3   27 , Bruno Hoen  30   3   27 ; Experts of the criteria weighting group (alphabetically) Experts of the entity rating group (alphabetically) Experts from Santé publique France who provided the quantitative data (alphabetically)
Collaborators, Affiliations

Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024

Dominique Ploin et al. Euro Surveill. 2024 Dec.

Abstract

BackgroundWithin the International Health Regulations framework, the French High Council for Public Health was mandated in 2022 by health authorities to establish a list of priority infectious diseases for public health, surveillance and research in mainland and overseas France.AimOur objective was to establish this list.MethodsA multi-criteria decision analysis was used, as recommended by the European Centre for Disease Prevention and Control. A list of 95 entities (infectious diseases or groups of these, including the World Health Organization (WHO)-labelled 'Disease X') was established by 17 infectious disease experts. Ten criteria were defined to score entities: incidence rate, case fatality rate, potential for emergence and spread, impact on the individual, on society, on socially vulnerable groups, on the healthcare system, and need for new preventive tools, new curative therapies, and surveillance. Each criterion was assigned a relative weight by 77 multidisciplinary experts. For each entity, 98 physicians from various specialties rated each criterion against the entity, using a four-class Likert-type scale; the ratings were converted into numeric values with a nonlinear scale and respectively weighted to calculate the entity score.ResultsFifteen entities were ranked as high-priorities, including Disease X and 14 known pathologies (e.g. haemorrhagic fevers, various respiratory viral infections, arboviral infections, multidrug-resistant bacterial infections, invasive meningococcal and pneumococcal diseases, prion diseases, rabies, and tuberculosis).ConclusionThe priority entities agreed with those of the WHO in 2023; almost all were currently covered by the French surveillance and alert system. Repeating this analysis periodically would keep the list updated.

Keywords: Communicable Diseases; Decision Support Techniques; France; Health Priorities; Humans; Public Health; Surveys and Questionnaires; epidemiology; multi-criteria decision analysis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: All the authors declare that they have no conflict of interest in relation to the content of the manuscript, notably in terms of financial or intellectual properties. No remuneration was perceived by any author for participating in this study.

Figures

Figure 1
Figure 1
Different phases of a study to establish a list of priority infectious entitiesa for France and its overseas territories, January−October 2023
Figure 2
Figure 2
Contribution of the different prioritisation criteria on the scores of high-priority infectious entities, France, 2024 (n = 14 entities)
See this image and copyright information in PMC

References

    1. Delfraissy JF. La recherche française face aux maladies infectieuses émergentes: de REACTing à l’ANRS- maladies infectieuses émergentes. [French research organization on emerging infectious diseases: From REACTing to ANRS emerging infectious diseases]. Bull Acad Natl Med. 2023;207(3):287-94. 10.1016/j.banm.2022.11.017 - DOI - PMC - PubMed
    1. Nacher M, Epelboin L, Bonifay T, Djossou F, Blaizot R, Couppié P, et al. Migration in French Guiana: Implications in health and infectious diseases. Travel Med Infect Dis. 2024;57:102677. 10.1016/j.tmaid.2023.102677 - DOI - PubMed
    1. Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, et al. Illegal gold miners in French Guiana: a neglected population with poor health. BMC Public Health. 2017;18(1):23. 10.1186/s12889-017-4557-4 - DOI - PMC - PubMed
    1. Belchior E, Henry S, Badell E, Collet L, Benoit-Cattin T, de Montera AM, et al. Diphtheria in Mayotte, 2007-2015. Emerg Infect Dis. 2017;23(7):1218-20. 10.3201/eid2307.170262 - DOI - PMC - PubMed
    1. World Health Organization (WHO). Biodiversity & Infectious Diseases. Questions & Answers. Geneva: WHO. [Accessed 27 Nov 2024]. Available from: https://www.who.int/docs/default-source/climate-change/qa-infectiousdise...

LinkOut - more resources